Diabetes and pancreatic surgery: how it affects blood sugar
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how different types of pancreatic surgery (removing part or all of the pancreas) affect blood sugar control in people who already have diabetes. It aims to understand how these operations change the body's metabolism and overall health, which may help improve care for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have diabetes before your surgery.
- You are scheduled to have surgery to remove part or all of your pancreas.
- Your surgery is for a non-cancerous or cancerous condition of the pancreas.
- You are willing to have your medical data collected for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who are having part or all of their pancreas removed due to disease. Researchers want to understand how this surgery affects blood sugar control, weight, and overall health in people without diabetes before surgery.
This study tests whether giving insulin after pancreatic surgery helps control blood sugar in patients who develop diabetes as a result of the surgery. It may help you manage your recovery better and avoid complications from high blood sugar.
This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.
This study looks at the risks of pancreas surgery in people with end-stage kidney disease (kidney failure). It aims to help doctors understand how safe these surgeries are for patients on dialysis or with kidney problems.
This study checks if high levels of a certain enzyme (called amylase) in the blood after pancreas surgery can help predict recovery and complications. The goal is to improve patient safety after the operation.
This study tests a hybrid closed-loop insulin delivery system (MiniMed 780G with Simplera sensor) in people who have had their pancreas removed. The system automatically adjusts insulin based on glucose levels, which may make diabetes management easier and safer.
Hear when a new Pancreatectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.